Effectiveness of acupuncture for cancer-related fatigue: a systematic reviews and meta-analysis - Report - MDSpire

Effectiveness of acupuncture for cancer-related fatigue: a systematic reviews and meta-analysis

Share

Clinical Report: Efficacy of Acupuncture in Alleviating Cancer-Related Fatigue

Overview

{'evidence_quality': 'Specify factors contributing to low evidence quality.'}

Background

{'non_pharmacological_examples': 'Add examples of non-pharmacological treatments.'}

Data Highlights

{'outcomes': 'Consider including additional outcomes if available.'}

Key Findings

{'risk_of_bias': 'Clarify the contradiction regarding risk of bias and evidence quality.'}

Clinical Implications

{'emphasis': 'Strengthen the call for high-quality studies.'}

Conclusion

{'methodological_concerns': 'Reiterate the need to address methodological issues.'}

References

  1. Frontiers | Effectiveness of Acupuncture for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis
  2. Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial - PubMed
  3. The ASCO Post — Electroacupuncture May Relieve Cognitive, Psychological Symptoms in Breast Cancer Survivors in Pilot Study
  4. The ASCO Post — Acupuncture: Does It Alleviate Symptoms Associated with Cancer Care?
  5. The ASCO Post — Self-Acupressure May Ease Fatigue in Ovarian Cancer Survivors
  6. The ASCO Post — Self-Acupressure May Ease Fatigue in Ovarian Cancer Survivors
  7. ASCO Special Articles
  8. Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial - PubMed
  9. Frontiers | Effectiveness of Acupuncture for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis

Original Source(s)

Effectiveness of acupuncture for cancer-related fatigue: a systematic reviews and meta-analysis

  • by Hongxiao Zhang, Zhifeng Pan, Yuting Huang, Run Lin, Liying Wang, Tao Peng, Mingzhu Xu, Zining Guo, Shaoyang Cui

  • May 5, 2026

Related Content

This Week’s Biopharma News: EU Clears First Pertuzumab Biosimilar

Plus: NICE backs rozanolixizumab for uncontrolled gMG, Genexine reports SOX2 degrader data, and BeOne secures option on Huahui trispecific antibody

  • May 5, 2026

  • 5 min
COA and Flatiron Health Study Finds Patients May Experience Longer Survival in Community Oncology Settings

Patients diagnosed with metastatic breast cancer and non–small cell lung cancer had longer survival compared to national benchmarks when treated in independent community oncology practices, according ...

Zoldonrasib in Patients With <em>KRAS</em> G12D–Mutant NSCLC Previously Treated With Chemoimmunotherapy

The investigational KRAS G12D inhibitor zoldonrasib had a favorable safety profile and induced antitumor activity in some patients with KRAS G12D–mutated non–small cell lung cancer (NSCLC) who were pr...